Home

Hrubě Netolerovatelné Identifikovat bio con anténa radar Osobní

Biocon Q4 results show Consolidated revenue up by 21% - The Statesman
Biocon Q4 results show Consolidated revenue up by 21% - The Statesman

Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance

Joint drugs controller nabbed taking bribe to clear Biocon Biologics's  diabetes injection | Mint
Joint drugs controller nabbed taking bribe to clear Biocon Biologics's diabetes injection | Mint

Covid has created an 'ecosystem' of innovation in India, says Biocon chief  Kiran Mazumdar-Shaw | Mint
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint

Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter |  Business Standard News
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News

True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3  billion | Mint
True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion | Mint

Biocon - Wikipedia
Biocon - Wikipedia

Biocon Biologics enters licensing agreement with Yoshindo of Japan - The  Hindu BusinessLine
Biocon Biologics enters licensing agreement with Yoshindo of Japan - The Hindu BusinessLine

Biocon - 72 new faces joined us in February. Many... | Facebook
Biocon - 72 new faces joined us in February. Many... | Facebook

Biocon announces merger of its arm with Serum Institute subsidiary -  BusinessToday
Biocon announces merger of its arm with Serum Institute subsidiary - BusinessToday

Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award  Winner | Pharmaceutical Engineering
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering

Biocon Biologics Receives USD 150 Million Capital Injection from Goldman  Sachs - Biocon
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon

Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion |  The Financial Express
Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion | The Financial Express

Biocon Campus - Biocon
Biocon Campus - Biocon

Manufacturing Locations - Biocon
Manufacturing Locations - Biocon

Manufacturing Operations - Biocon - Global Biopharmaceutical company
Manufacturing Operations - Biocon - Global Biopharmaceutical company

Biocon Biologics (@BioconBiologics) / Twitter
Biocon Biologics (@BioconBiologics) / Twitter

Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award  Winner | Pharmaceutical Engineering
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering

Biocon logo in transparent PNG format
Biocon logo in transparent PNG format

Biocon Academy - Biocon
Biocon Academy - Biocon

Fortune India: Business News, Strategy, Finance and Corporate Insight
Fortune India: Business News, Strategy, Finance and Corporate Insight

Biocon Campus - Biocon
Biocon Campus - Biocon

Biocon biosimilar plant criticized again by the FDA | Fierce Pharma
Biocon biosimilar plant criticized again by the FDA | Fierce Pharma

Research Centre - Biocon
Research Centre - Biocon

Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to  Buy Additional Stake of $500 Million in Biocon Biologics: Sources
Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources

BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView